FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

779850004: Product containing only methyclothiazide and reserpine in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3741428014 Product containing only methyclothiazide and reserpine in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3741429018 Methyclothiazide and reserpine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3741428014 Product containing only methyclothiazide and reserpine in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3741429018 Methyclothiazide and reserpine only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5571221000241119 produit contenant seulement du méthyclothiazide et de la réserpine sous forme orale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5571221000241119 produit contenant seulement du méthyclothiazide et de la réserpine sous forme orale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyclothiazide and reserpine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Reserpine true Inferred relationship Existential restriction modifier (core metadata concept) 2
Methyclothiazide and reserpine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methyclothiazide (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyclothiazide and reserpine only product in oral dose form Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Methyclothiazide and reserpine only product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Methyclothiazide and reserpine only product in oral dose form Is a Methyclothiazide and reserpine only product true Inferred relationship Existential restriction modifier (core metadata concept)
Methyclothiazide and reserpine only product in oral dose form Is a Product containing methyclothiazide and reserpine in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Methyclothiazide and reserpine only product in oral dose form Plays role Diuretic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a True Methyclothiazide and reserpine only product in oral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start